Mark N Prichard Selected Research

Mark N Prichard Research Topics

Disease

26	Infections 01/2023 - 03/2005
5	Poxviridae Infections 05/2012 - 03/2005
4	Virus Diseases (Viral Diseases) 05/2014 - 11/2008
4	Human Influenza (Influenza) 02/2014 - 10/2009
4	Smallpox (Variola) 11/2011 - 03/2005
4	Cowpox 05/2011 - 01/2006
4	Vaccinia 05/2011 - 03/2005
3	Cytomegalovirus Infections (Inclusion Disease) 11/2018 - 05/2011
2	Body Weight (Weight, Body) 10/2020 - 11/2007
2	DNA Virus Infections 11/2018 - 11/2018
2	Herpesviridae Infections (Herpesvirus Infection) 12/2011 - 04/2006
2	Ectromelia (Phocomelia) 05/2011 - 12/2009
2	Retinoblastoma (Glioblastoma, Retinal) 07/2009 - 05/2008
1	Bronchopulmonary Dysplasia 01/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 01/2018
1	Influenza in Birds (Avian Flu) 02/2014
1	Hemolysis 02/2014
1	Herpetic Keratitis 11/2013
1	Bacterial Vaginosis 04/2012
1	HIV Infections (HIV Infection) 12/2008
1	Chickenpox 10/2008
1	Herpes Zoster 10/2008
1	Neuroblastoma 10/2008
1	Cytomegalovirus Retinitis 05/2008
1	Leukemia 05/2008
1	Epstein-Barr Virus Infections 09/2007
1	Genital Diseases 11/2005
1	Herpes Genitalis (Genital Herpes) 11/2005

Drug/Important Bio-Agent (IBA)

17	Antiviral Agents (Antivirals)IBA 11/2018 - 03/2005
7	Cidofovir (Vistide)FDA Link 01/2023 - 03/2005
6	Acyclovir (Aciclovir)FDA LinkGeneric 01/2018 - 10/2008
4	Ganciclovir (Cytovene)FDA LinkGeneric 11/2018 - 05/2011
4	Oseltamivir (Tamiflu)FDA Link 02/2014 - 10/2009
4	NucleosidesIBA 01/2014 - 02/2007
4	EstersIBA 05/2011 - 09/2005
3	brincidofovirIBA 07/2016 - 11/2007
3	Foscarnet FDA LinkGeneric 12/2014 - 10/2008
3	Organophosphonates (Phosphonates)IBA 12/2008 - 02/2007
3	VaccinesIBA 11/2008 - 11/2005
2	Thymidine KinaseIBA 07/2015 - 04/2006
2	Glycoproteins (Glycoprotein)IBA 02/2014 - 11/2008
2	Proteins (Proteins, Gene)FDA Link 11/2011 - 05/2008
2	DNA (Deoxyribonucleic Acid)IBA 05/2011 - 09/2007
2	Neuraminidase (Sialidase)IBA 02/2010 - 10/2009
2	Ribavirin (Virazole)FDA LinkGeneric 02/2010 - 10/2009
2	Amantadine (Aman)FDA LinkGeneric 02/2010 - 10/2009
2	Phosphotransferases (Kinase)IBA 07/2009 - 12/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Viral ProteinsIBA 01/2019
1	letermovirIBA 11/2018
1	pritelivirIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 05/2014
1	Codon (Codons)IBA 05/2014
1	Antithrombin IIIIBA 04/2014
1	SerpinsIBA 04/2014
1	Monoclonal AntibodiesIBA 02/2014
1	Hemagglutinins (Hemagglutinin)IBA 02/2014
1	methylenecyclopropaneIBA 01/2014
1	Lysine (L-Lysine)FDA Link 04/2012
1	Antimicrobial PeptidesIBA 04/2012
1	Bacillus subtilis sboA proteinIBA 04/2012
1	N(alpha)-lauroylarginine ethyl esterIBA 04/2012
1	monolaurinIBA 04/2012
1	Idoxuridine (Stoxil)FDA LinkGeneric 09/2010
1	pyrimidineIBA 09/2010
1	thiazole-4-carboxamide adenine dinucleotide (TCAD)IBA 02/2010
1	9- (3- hydroxy- 2- phosphonomethoxypropyl)- 2,6- diaminopurineIBA 12/2009
1	ThymineIBA 12/2009
1	9- (3- hydroxy- 2- phosphonomethoxypropyl)guanineIBA 12/2009
1	GuanineIBA 12/2009
1	RNA Polymerase II (RNA Polymerase B)IBA 07/2009
1	Peptide Elongation Factor 1 (EF-1)IBA 07/2009
1	LaminsIBA 07/2009
1	maribavirIBA 07/2009
1	glycoprotein D-herpes simplex virus type 2IBA 11/2008
1	Quillaja SaponinsIBA 11/2008
1	Therapeutic UsesIBA 11/2008
1	GPI0100IBA 11/2008
1	NucleotidesIBA 05/2008
1	tecovirimatIBA 11/2007
1	Dihydrotachysterol (AT 10)IBA 11/2007
1	Viral DNAIBA 09/2007
1	Tenofovir (Viread)FDA Link 02/2007
1	adefovir dipivoxil (Hepsera)FDA Link 02/2007
1	EnzymesIBA 04/2006
1	(north)-methanocarbathymidineIBA 04/2006
1	7-deazaneplanocin AIBA 01/2006
1	Attenuated VaccinesIBA 11/2005
1	LipidsIBA 09/2005
1	Methisazone (Metisazone)IBA 03/2005

Therapy/Procedure

17	Therapeutics 11/2018 - 03/2005
2	Emergency Treatment 05/2008 - 03/2005
1	Oral Administration 10/2020
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Drug Therapy (Chemotherapy) 10/2008
1	Stem Cell Transplantation 10/2008